An important next step will be to determine whether elevations in FGF21 are coupled to specific changes in FGF21 receptors or to factors binding to the receptors that render it less efficacious following repeated stimulation, and how it can be best targeted to treat metabolic diseases. This evidence concerns the gene FGF21 and Other metabolic disease.